CNS Pharmaceuticals, Inc. Prepaid Expense and Other Assets, Current
CNS Pharmaceuticals, Inc. (CNSP) had Prepaid Expense and Other Assets, Current of $1.86 million as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-12
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.86M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.10M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $856.00K; Prepaid Expense and Other Assets, Current as first filed $856.30K.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.48M.
| Period end | Prepaid Expense and Other Assets, Current | Prepaid Expense and Other Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.86M 10-Q · filed 2026-08-12 | |
| 2026-03-31 | $1.10M 10-Q · filed 2026-05-14 | |
| 2025-12-31 | $856.00K 10-Q · filed 2026-08-12 | $856.30K 10-K · filed 2026-03-31 |
| 2025-09-30 | $1.48M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $1.99M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $653.80K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $1.29M 10-K · filed 2026-03-31 | |
| 2024-09-30 | $388.04K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $637.09K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $786.05K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $839.59K 10-K · filed 2025-03-31 | |
| 2023-09-30 | $1.15M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $1.79M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $1.86M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.51M 10-K · filed 2024-04-01 | |
| 2021-12-31 | $2.47M 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |